Sadaf Aftab Inamdar, BPharm

Pune, India
Role: 
Staff
Pharmacist of Record
Sadaf Aftab Inamdar, BPharm

Ms. Inamdar is a Pharmacist of Record at BJGMC-CRS, Pune, where she is responsible for study product management, supervision and training for pharmacy staff, establishment and implementation of internal policies and procedures, QA/QC management, inventory control, randomization procedures, study product preparation and dispensing, as well as counseling study participants regarding treatments, adherence monitoring, and product destruction. She is also responsible for preparing the applications for the in-country drug regulatory authority, DCGI and Zonal Officer CDSCO Mumbai. She is also responsible for clearing the shipments from customs by coordinating with clearing agent and customs office. Currently dealing with GST taxation issues. She is knowledgeable about all protocols conducted at BJGMC-CRS, and is well trained in Good Clinical Practices.

She has 16 years of experience in the field of clinical trials at BJGMC-CRS. She worked as Study Pharmacist for a Phase III Clinical Trial ‘Six Weeks Extended Nevirapine’ (SWEN study) in infants to prevent vertical HIV transmission via breastfeeding, conducted in collaboration with Johns Hopkins University, Baltimore, USA. She was responsible for managing all the pharmacy related activities.

She served as an International Committee member on the Adult Clinical Trial Group (ACTG ) Pharmacy Subcommittee from 2009 until January 31, 2014. She also served as Non-voting member on International Maternal Pediatric Adolescent AIDS Clinical Trial (IMPAACT) Pharmacy Resource Committee, 2010-2013.

She worked as Pharmacist of Record for many multinational HIV network studies, including IMPAACT P1060, P1070, and PROMISE study, and ACTG A5207, A5225, A5274, and A5273 studies.

Ms. Inamdar is a qualified registered pharmacist with a degree in Pharmacy (BPharm), and she completed a certificate course in Clinical Research and Data Management from Pune University.

Up Close with Sadaf Inamdar. 2016-07-01

BWI CTU: Baltimore-Washington-India Clinical Trials Unit

Post Date: 
2007-02-02
Comprising clinical trial sites at Johns Hopkins Medicine in Baltimore, Whitman Walker Health in Washington, DC, and the BJGMC-CCGHE collaboration in Pune, India, the Baltimore-Washington-India Clinical Trials Unit (BWI-CTU) is one of only 25 international HIV/TB clinical trial sites funded by the...

Mother-to-Child Transmission (MTCT) of HIV: India SWEN Study

Post Date: 
2002-06-07
Country: 
Primary and secondary analyses of the India SWEN study, an NIH-funded phase III randomized controlled trial of an extended nevirapine prophylaxis regimen among 783 HIV-infected pregnant women and their breastfed infants in Pune, India.

Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomized controlled trials

Post Date: 
2009-07-26
Publication: 
The Lancet
Background: UNICEF/WHO recommends that infants born to HIV-infected mothers who do not have access to acceptable, feasible, affordable, sustainable, and safe replacement feeding should be exclusively breastfed for at least 6 months. The aim of three trials in Ethiopia, India, and Uganda was to...

Up Close: Sadaf Inamdar

Post Date: 
2016-07-01
The integrity of clinical trials relies on pharmacological expertise. The pharmacy at the BJGMC site is in capable hands.